Riskpilot← Back to searchSign inGet full accessInjection Technology NMC Aktiebolag
ABActiveOrg 5562495357Kyrkbacken 2Engineering activities and related technical consultancy · NACE 7112Est. 19850 employees
Revenue 2025
—
EBITDA margin
—
-82% vs 2024
Equity ratio
77.3%
Financial strength
Net profit 2025
SEK 761K
+29% vs 2024
| Revenue | — | — |
| EBITDA | SEK -169K | -82% |
| Net profit | SEK 761K | +29% |
| Total assets | SEK 11M | +5% |
| Equity | SEK 8,5M | +10% |
| Employees | 0 | — |
Legal name
Injection Technology NMC Aktiebolag
Org number
5562495357
Legal form
Aktiebolag
NACE code
7112 · Engineering activities and related technical consultancy
Founded
18 mars 1985
Share capital
SEK 100 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva försäljning och tillverkning av utrustningar för metallurgisk industri, bedriva konsultverksamhet inom företags- och fastighetsutveckling samt därmed förenlig verksamhet.
Address
Kyrkbacken 2
Email
intec.viken@telia.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | — | — | — |
| Staff expenses | — | −0 | — | — | — |
| EBITDA | −405 | −99 | −59 | −93 | −169 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −405 | −99 | −59 | −93 | −169 |
| Net financials | 1 289 | 1 224 | 952 | 694 | 940 |
| Profit before tax | 1 184 | 1 195 | 1 012 | 721 | 929 |
| Tax | −222 | −112 | −191 | −131 | −168 |
| Net profit | 962 | 1 083 | 822 | 589 | 761 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 7 989 | 9 389 | 10 125 | 10 507 | 11 042 |
| Equity | 5 278 | 6 362 | 7 183 | 7 773 | 8 534 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 2 242 | 2 630 | 2 664 | 2 577 | 2 508 |
| Total debt | 2 242 | 2 630 | 2 664 | 2 577 | 2 508 |
EBITDA margin
-16867100.0%
This company
15.8%
Market median
-106753897% vs market
20212025
Equity ratio
77.3%
This company
38.2%
Market median
+102% vs market
20212025
Return on equity
8.9%
This company
18.4%
Market median
-52% vs market
20212025
Net profit margin
76091700.0%
This company
8.1%
Market median
+939403604% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.29×
This company
0.62×
Market median
+53% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NM Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2025 | |
| Former (1) | ||
| Board of Directors | 2022 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Injection Technology NMC Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Magnus Vilhelm Cederblad | Chief Executive Officer | 0 companies |
| Krister Stig Herman Wagenius | Board of Directors | 0 companies |
| Lars-Ola Fredrik Leo | Deputy Board Member | 0 companies |